By: McKesson MedSurg Editorial Team
Read time: 5 minutes
There are important differences between biosimilars and biologics. Research and studies show that the use of biosimilar drugs can save money for both patients and providers, and increased affordability of biosimilars can have a meaningful impact on the healthcare system.
To dive deeper into the differences, examining the costs and benefits, Derek Burns and Tim Ho, clinical specialists at McKesson, share their insights on biosimilars and discuss their expert knowledge of these new products.
Share
Post
Post
Email